Venture Capital
Five VCs discuss what surprised them the most in 2020
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast (now on Twitter!), where we unpack the numbers behind the headlines. Today is our holiday look-back
US seed-stage investing flourished during pandemic
As the United States entered its first wave of COVID-19 lockdowns, there were wide expectations in startup land that a reckoning had arrived. But the
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
Heading into 2021: Venture fundraising, liquidity and the everything bubble
The last 12 months have provided us with shocking lows and surprising highs. In startup land, great expectations in January and February were followed by
What’s normal today could be redundant tomorrow
Singlera Genomics, LeadSquared, Next Innovation, and more startups raised funds this week. source : techinasia
